Skip to main content
Erschienen in: Journal of Genetic Counseling 5/2016

07.03.2016 | Original Research

Experiences of Being Heterozygous for Fabry Disease: a Qualitative Study

verfasst von: Charlotte von der Lippe, Jan C. Frich, Anna Harris, Kari Nyheim Solbrække

Erschienen in: Journal of Genetic Counseling | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Little is known about the experiences of women with Fabry disease. The aim of this study was to explore women’s experiences of being heterozygous for Fabry disease. We used an explorative qualitative study design and selected ten Norwegian women who were known heterozygous for Fabry disease to participate. We conducted in-depth semi-structured interviews and analyzed the interviews using inductive thematic analysis. We found that learning about one’s heterozygous status may be devastating for some. However, for most of the participants, heterozygous status, as well as doctors’ acceptance of symptoms in women heterozygous for Fabry disease, provided an explanation and relief. Although many women did not consider themselves ill, they wished to be acknowledged as more than “just carriers.” The participants were grateful for enzyme replacement therapy, although it had its burdens regarding time, planning, and absences from school or work. Women with Fabry disease felt that the lack of knowledge among healthcare professionals about Fabry disease was frustrating and worrisome. These findings suggest that healthcare professionals should acknowledge the different ways women react to their diagnosis, and be aware of the personal costs of receiving treatment.
Literatur
Zurück zum Zitat Album, D., & Westin, S. (2008). Do diseases have a prestige hierarchy? A survey among physicians and medical students. Social Sciences & Medicine, 66(1), 182–-188. Album, D., & Westin, S. (2008). Do diseases have a prestige hierarchy? A survey among physicians and medical students. Social Sciences & Medicine, 66(1), 182–-188.
Zurück zum Zitat Braun, V. & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101.CrossRef Braun, V. & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101.CrossRef
Zurück zum Zitat Bury, M. (1982). Chronic illness as biographical disruption. Sociology of Health & Illness, 4(2), 167–182.CrossRef Bury, M. (1982). Chronic illness as biographical disruption. Sociology of Health & Illness, 4(2), 167–182.CrossRef
Zurück zum Zitat Charmaz, K. (1983). Loss of self: a fundamental form of suffering in the chronically ill. Sociology of Health & Illness, 5(2), 168–195.CrossRef Charmaz, K. (1983). Loss of self: a fundamental form of suffering in the chronically ill. Sociology of Health & Illness, 5(2), 168–195.CrossRef
Zurück zum Zitat Dures, E., Morris, M., Gleeson, K., & Rumsey, N. (2011). The psychosocial impact of epidermolysis bullosa. Qualitative Health Research, 21(6), 771–782.CrossRefPubMed Dures, E., Morris, M., Gleeson, K., & Rumsey, N. (2011). The psychosocial impact of epidermolysis bullosa. Qualitative Health Research, 21(6), 771–782.CrossRefPubMed
Zurück zum Zitat Forrest, K., Simpson, S. A., Wilson, B. J., van Teijlingen, E. R., McKee, L., Haites, N., et al. (2003). To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clinical Geneicst, 64(4), 317–326.CrossRef Forrest, K., Simpson, S. A., Wilson, B. J., van Teijlingen, E. R., McKee, L., Haites, N., et al. (2003). To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clinical Geneicst, 64(4), 317–326.CrossRef
Zurück zum Zitat Forrest, L. E., Burke, J., Bacic, S., & Amor, D. J. (2008). Increased genetic counseling support improves communication of genetic information in families. Genetics in Medicine, 10(3), 167–172.CrossRefPubMed Forrest, L. E., Burke, J., Bacic, S., & Amor, D. J. (2008). Increased genetic counseling support improves communication of genetic information in families. Genetics in Medicine, 10(3), 167–172.CrossRefPubMed
Zurück zum Zitat Frich, J. C., Malterud, K., & Fugelli, P. (2007). Experiences of guilt and shame in patients with familial hypercholesterolemia: a qualitative interview study. Patient Education and Counseling, 69(1–-3), 108–113.CrossRefPubMed Frich, J. C., Malterud, K., & Fugelli, P. (2007). Experiences of guilt and shame in patients with familial hypercholesterolemia: a qualitative interview study. Patient Education and Counseling, 69(1–-3), 108–113.CrossRefPubMed
Zurück zum Zitat Gele, A. A. & Harslof, I. (2010). Types of social capital resources and self-rated health among the Norwegian adult population. International Journal for Equity in Health, 9. doi:10.1186/1475-9276-9-8. Gele, A. A. & Harslof, I. (2010). Types of social capital resources and self-rated health among the Norwegian adult population. International Journal for Equity in Health, 9. doi:10.​1186/​1475-9276-9-8.
Zurück zum Zitat Gibas, A. L., Klatt, R., Johnson, J., Clarke, J. T., & Katz, J. (2008). Disease rarity, carrier status, and gender: a triple disadvantage for women with Fabry disease. Journal of Genetic Counseling, 17(6), 528–537.CrossRefPubMed Gibas, A. L., Klatt, R., Johnson, J., Clarke, J. T., & Katz, J. (2008). Disease rarity, carrier status, and gender: a triple disadvantage for women with Fabry disease. Journal of Genetic Counseling, 17(6), 528–537.CrossRefPubMed
Zurück zum Zitat Goffman, E. (1963). Stigma: notes on the management of spoiled identity (1986 ed.). New York: Simon & Schuster, Inc.. Goffman, E. (1963). Stigma: notes on the management of spoiled identity (1986 ed.). New York: Simon & Schuster, Inc..
Zurück zum Zitat Hallowell, N. (1999). Doing the right thing: genetic risk and responsibility. Sociology of Health & Illness, 21(5), 597–621.CrossRef Hallowell, N. (1999). Doing the right thing: genetic risk and responsibility. Sociology of Health & Illness, 21(5), 597–621.CrossRef
Zurück zum Zitat Helm, B. (2015). Exploring the Genetic Counselor’s Role in Facilitating Meaning-Making: Rare Disease Diagnoses. Journal of Genetic Counseling, 24(2), 205–212.CrossRefPubMed Helm, B. (2015). Exploring the Genetic Counselor’s Role in Facilitating Meaning-Making: Rare Disease Diagnoses. Journal of Genetic Counseling, 24(2), 205–212.CrossRefPubMed
Zurück zum Zitat Hesse-Bieber, S., Dupuis, P., & Kinder, T. S. (1991). HyperRESEARCH: a computer program for the analysis of qualitative data with an emphasis on hypothesis testing and multimedia analysis. Qualitative Sociology, 14, 289–306. Hesse-Bieber, S., Dupuis, P., & Kinder, T. S. (1991). HyperRESEARCH: a computer program for the analysis of qualitative data with an emphasis on hypothesis testing and multimedia analysis. Qualitative Sociology, 14, 289–306.
Zurück zum Zitat Inoue, T., Hattori, K., Ihara, K., Ishii, A., Nakamura, K., & Hirose, S. (2013). Newborn screening for Fabry disease in Japan: prevalence and genotypes of Fabry disease in a pilot study. Journal of Human Genetics, 58(8), 548–552.CrossRefPubMed Inoue, T., Hattori, K., Ihara, K., Ishii, A., Nakamura, K., & Hirose, S. (2013). Newborn screening for Fabry disease in Japan: prevalence and genotypes of Fabry disease in a pilot study. Journal of Human Genetics, 58(8), 548–552.CrossRefPubMed
Zurück zum Zitat Jaeger, G., Rojvik, A., & Berglund, B. (2015). Participation in society for people with a rare diagnosis. Disability and Health Journal, 8(1), 44–50.CrossRefPubMed Jaeger, G., Rojvik, A., & Berglund, B. (2015). Participation in society for people with a rare diagnosis. Disability and Health Journal, 8(1), 44–50.CrossRefPubMed
Zurück zum Zitat James, C. A., Hadley, D. W., Holtzman, N. A., & Winkelstein, J. A. (2006). How does the mode of inheritance of a genetic condition influence families? A study of guilt, blame, stigma, and understanding of inheritance and reproductive risks in families with X-linked and autosomal recessive diseases. Genetics in Medicine, 8(4), 234–242.CrossRefPubMed James, C. A., Hadley, D. W., Holtzman, N. A., & Winkelstein, J. A. (2006). How does the mode of inheritance of a genetic condition influence families? A study of guilt, blame, stigma, and understanding of inheritance and reproductive risks in families with X-linked and autosomal recessive diseases. Genetics in Medicine, 8(4), 234–242.CrossRefPubMed
Zurück zum Zitat Kay, E. & Kingston, H. (2002). Feelings Associated with Being a Carrier and Characteristics of Reproductive Decision Making in Women Known to Be Carriers of X-linked Conditions. Journal of Health Psychology, 7(2), 169–181.CrossRefPubMed Kay, E. & Kingston, H. (2002). Feelings Associated with Being a Carrier and Characteristics of Reproductive Decision Making in Women Known to Be Carriers of X-linked Conditions. Journal of Health Psychology, 7(2), 169–181.CrossRefPubMed
Zurück zum Zitat Laney, D. A., Bennett, R. L., Clarke, V., Fox, A., Hopkin, R. J., Johnson, et al. (2013). Fabry disease practice guidelines: recommendations of the National Society of Genetic Counselors. Journal of Genetic Counseling, 22(5), 555–564.CrossRefPubMed Laney, D. A., Bennett, R. L., Clarke, V., Fox, A., Hopkin, R. J., Johnson, et al. (2013). Fabry disease practice guidelines: recommendations of the National Society of Genetic Counselors. Journal of Genetic Counseling, 22(5), 555–564.CrossRefPubMed
Zurück zum Zitat Laney, D. A. & Fernhoff, P. M. (2008). Diagnosis of Fabry disease via analysis of family history. Journal of Genetic Counseling, 17(1), 79–83.CrossRefPubMed Laney, D. A. & Fernhoff, P. M. (2008). Diagnosis of Fabry disease via analysis of family history. Journal of Genetic Counseling, 17(1), 79–83.CrossRefPubMed
Zurück zum Zitat Lewis, C., Skirton, H., & Jones, R. (2012). Reproductive empowerment: the main motivator and outcome of carrier testing. Journal of Health Psychology, 17(4), 567–578.CrossRefPubMed Lewis, C., Skirton, H., & Jones, R. (2012). Reproductive empowerment: the main motivator and outcome of carrier testing. Journal of Health Psychology, 17(4), 567–578.CrossRefPubMed
Zurück zum Zitat Mechtler, T. P., Stary, S., Metz, T. F., De Jesus, V. R., Greber-Platzer, S., Pollak, A., et al. (2012). Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria. Lancet, 379(9813), 335–341.CrossRefPubMed Mechtler, T. P., Stary, S., Metz, T. F., De Jesus, V. R., Greber-Platzer, S., Pollak, A., et al. (2012). Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria. Lancet, 379(9813), 335–341.CrossRefPubMed
Zurück zum Zitat Pajari, H. & Sinkkonen, J. (2000). Psychosocial impact of an X-linked hereditary disease: a study of Alport syndrome patients and family members. Child: Care, Health and Development, 26(3), 239–250. Pajari, H. & Sinkkonen, J. (2000). Psychosocial impact of an X-linked hereditary disease: a study of Alport syndrome patients and family members. Child: Care, Health and Development, 26(3), 239–250.
Zurück zum Zitat Sadek, J., Shellhaas, R., Camfield, C. S., Camfield, P. R., & Burley, J. (2004). Psychiatric findings in four female carriers of Fabry disease. Psychiatric Genetics, 14(4), 199–201.CrossRefPubMed Sadek, J., Shellhaas, R., Camfield, C. S., Camfield, P. R., & Burley, J. (2004). Psychiatric findings in four female carriers of Fabry disease. Psychiatric Genetics, 14(4), 199–201.CrossRefPubMed
Zurück zum Zitat Schiffmann, R., Kopp, J. B., Austin, H. A., et al. (2001). Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA, 285(21), 2743–2749.CrossRefPubMed Schiffmann, R., Kopp, J. B., Austin, H. A., et al. (2001). Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA, 285(21), 2743–2749.CrossRefPubMed
Zurück zum Zitat Spada, M., Pagliardini, S., Yasuda, M., Tukel, T., Thiagarajan, G., Sakuraba, H.,.. . .. Desnick, R. J. (2006). High incidence of later-onset fabry disease revealed by newborn screening. American Journal of Human Genetics, 79(1), 31–-40.CrossRefPubMedPubMedCentral Spada, M., Pagliardini, S., Yasuda, M., Tukel, T., Thiagarajan, G., Sakuraba, H.,.. . .. Desnick, R. J. (2006). High incidence of later-onset fabry disease revealed by newborn screening. American Journal of Human Genetics, 79(1), 31–-40.CrossRefPubMedPubMedCentral
Zurück zum Zitat Stamm, T., Lovelock, L., Stew, G., Nell, V., Smolen, J., Machold, K., et al. (2009). I have a disease but I am not ill: A narrative study of occupational balance in people with rheumatoid arthritis. OTJR: Occupation, Participation and Health, 29(1), 32–39. Stamm, T., Lovelock, L., Stew, G., Nell, V., Smolen, J., Machold, K., et al. (2009). I have a disease but I am not ill: A narrative study of occupational balance in people with rheumatoid arthritis. OTJR: Occupation, Participation and Health, 29(1), 32–39.
Zurück zum Zitat Street, N. J., Yi, M. S., Bailey, L. A., & Hopkin, R. J. (2006). Comparison of health-related quality of life between heterozygous women with Fabry disease, a healthy control population, and patients with other chronic disease. Genetics in Medicine, 8(6), 346–353.CrossRefPubMed Street, N. J., Yi, M. S., Bailey, L. A., & Hopkin, R. J. (2006). Comparison of health-related quality of life between heterozygous women with Fabry disease, a healthy control population, and patients with other chronic disease. Genetics in Medicine, 8(6), 346–353.CrossRefPubMed
Zurück zum Zitat Tilden, B., Charman, D., Sharples, J., & Fosbury, J. (2005). Identity and adherence in a diabetes patient: Transformations in psychotherapy. Qualitative Health Research, 15(3), 312–324.CrossRefPubMed Tilden, B., Charman, D., Sharples, J., & Fosbury, J. (2005). Identity and adherence in a diabetes patient: Transformations in psychotherapy. Qualitative Health Research, 15(3), 312–324.CrossRefPubMed
Zurück zum Zitat Van Manen, M. (1998). Modalities of body experience in illness and health. Quaitativel Health Research, 8(1), 7–24.CrossRef Van Manen, M. (1998). Modalities of body experience in illness and health. Quaitativel Health Research, 8(1), 7–24.CrossRef
Zurück zum Zitat Wallenius, E., Möller, K., & Berglund, B. (2009). Everyday Impact of Having a Rare Diagnosis. A Questionnaire Study. Nordic Journal of Nursing Research, 29(3), 13–17.CrossRef Wallenius, E., Möller, K., & Berglund, B. (2009). Everyday Impact of Having a Rare Diagnosis. A Questionnaire Study. Nordic Journal of Nursing Research, 29(3), 13–17.CrossRef
Zurück zum Zitat Wang, R. Y., Lelis, A., Mirocha, J., & Wilcox, W. R. (2007). Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life. Genetics in Medicine, 9(1), 34–45.CrossRefPubMed Wang, R. Y., Lelis, A., Mirocha, J., & Wilcox, W. R. (2007). Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life. Genetics in Medicine, 9(1), 34–45.CrossRefPubMed
Zurück zum Zitat Wilcox, W. R., Oliveira, J. P., Hopkin, R. J., Ortiz, A., Banikazemi, M., et al. (2008). Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Molecular Genetetics and Metabolism, 93(2), 112–128.CrossRef Wilcox, W. R., Oliveira, J. P., Hopkin, R. J., Ortiz, A., Banikazemi, M., et al. (2008). Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Molecular Genetetics and Metabolism, 93(2), 112–128.CrossRef
Zurück zum Zitat Williams, J. K., & Schutte, D. L. (1997). Benefits and burdens of genetic carrier identification. Western Journal of Nursing Resarch, 19(1), 71–-81. Williams, J. K., & Schutte, D. L. (1997). Benefits and burdens of genetic carrier identification. Western Journal of Nursing Resarch, 19(1), 71–-81.
Metadaten
Titel
Experiences of Being Heterozygous for Fabry Disease: a Qualitative Study
verfasst von
Charlotte von der Lippe
Jan C. Frich
Anna Harris
Kari Nyheim Solbrække
Publikationsdatum
07.03.2016
Verlag
Springer US
Erschienen in
Journal of Genetic Counseling / Ausgabe 5/2016
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-016-9941-1

Weitere Artikel der Ausgabe 5/2016

Journal of Genetic Counseling 5/2016 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.